Navigation Links
Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd
Date:10/12/2010

-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct preclinical and clinical development of its potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2009, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
2. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
3. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
4. Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders
5. Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
6. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
7. Lexicons Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
8. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
9. Lexicon Announces Pricing of Common Stock in Public Offering
10. Lexicon Announces Completion of Public Offering of Common Stock
11. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... Texas , April 27, 2015 /PRNewswire/ ... company focused on gynecologic disease, announced today ... results after the market close on Monday, ... conference call and webcast at 4:30pm Eastern.Conference ... at 4:30pm Eastern/1:30pm Pacific Domestic: , 888-556-4997International: ...
(Date:4/27/2015)... -- Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company ... B virus (HBV) infection, today announced the presentation of ... candidate, NVR 3-778, at the 2015 annual meeting of ... (EASL) in Vienna, Austria . ... performed in a humanized UPA/SCID mouse model was described ...
(Date:4/27/2015)... , April 27, 2015 Endo International plc (NASDAQ: ... 2015 financial results before the open of the U.S. financial ... management team will host a conference call and webcast at ... number to access the call is U.S./ Canada ... is 34236444. Please dial in 10 minutes prior to the ...
Breaking Medicine Technology:Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 2Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 3
... Oct. 8 Throughout October, National Breast Cancer Awareness ... its clinical care partner, the Seattle Cancer Care Alliance, ... regarding a variety of topics related to breast cancer, ... and survivorship. The series will conclude Friday, Oct. 22. ...
... Synapse Biomedical Inc . announces today ... Administration (FDA) designation of the NeuRx Diaphragm Pacing ... for amyotrophic lateral sclerosis ( ALS ) patients with ... has now submitted for Humanitarian Device Exemption (HDE) approval. ...
Cached Medicine Technology:10 Tips for Breast Cancer Screening and Early Detection 210 Tips for Breast Cancer Screening and Early Detection 310 Tips for Breast Cancer Screening and Early Detection 4Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) 2Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) 3Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS) 4
(Date:4/27/2015)... Jackson, Tennessee (PRWEB) April 27, 2015 A ... to help young people trapped in substance abuse. Programming for ... which will serve girls, is launching this summer. , The ... more than $100,000 to serve adolescents. The Youth Town Jim ... in Collierville on Monday, May 4, with tee times at ...
(Date:4/27/2015)... MD (PRWEB) April 27, 2015 Jesse ... the 2015–2020 United States Pharmacopeial Convention (USP) at the ... is Professor of Medicine at Georgetown University and the ... and Stewardship (COMPASS). , As USP President, a volunteer ... Convention Meeting. He will be a voting member, ex ...
(Date:4/27/2015)... UC Davis investigators have settled a ... inherited disorder that historically affected Ashkenazi Jews from ... populations of Semitic descent, particularly families from Saudi ... the researchers uncovered the biochemical underpinnings of Canavan ... incurable and progressively fatal neurological condition. The UC ...
(Date:4/27/2015)... Based in the Twin Cities of Minneapolis and ... insurance marketing organizations in the country focused on delivering ... as well as employer sponsored ancillary benefits. Spending two ... opportunity to consult with disability insurance carriers, helping to ... , An example of these programs include the most ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 On April 16, ... Get Rid of Stretch Marks ,” interviewed a UK ... . Stretch marks are a type of scar ... are caused by a breakdown of the elsastin and collagen ... (see: goo.gl/iRdmEe) , “Stretch mark removal with the Coolbeam ...
Breaking Medicine News(10 mins):Health News:Golf, Sermon on the Mount and More to Support Youth Town’s Jericho and Eden Programs 2Health News:Dr. Jesse Goodman Elected President of the USP Convention 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 3Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 4Health News:Simplified Solutions Now Makes Disability Insurance Business With Secura Consultants Even Easier! 2Health News:Stretch Marks: The Latest Treatment Options for Stretch Mark Removal 2
... Inc.,(Nasdaq: NXTM ), a leading manufacturer of innovative ... its common stock and,warrants. The private placement consists of ... of $4.50 per share and warrants to purchase 1.9,million ... $5.50 per share,which price may be adjusted to $3.00 ...
... /Xinhua-PRNewswire-FirstCall/ -- Linkwell,Corporation (Linkwell) (OTC Bulletin Board: ... healthcare related disinfectants in China,announced today that ... of China,s,earthquake relief efforts. The Chinese government, ... on an,unprecedented scale in response to the ...
... May 23 Kellogg Company today,announced a $250,000 donation ... efforts in the Sichuan province in southwestern China.,The contribution ... be designated to support the efforts of the Red ... work ahead as people mobilize to rebuild their lives,and ...
... Center (MUMC) now offers a type of gallbladder ... belly button. It,s called single,incision laparoscopic surgery, or ... the SILS technique. One of them is Christopher ... the gallbladder through a,1cm. incision in the belly ...
... from the Peninsula Medical School in Cornwall, UK, have ... topically applied cream with visible light to destroy cancer ... is applied directly to skin cancers and pre-cancers, which ... red light is then shone on the tumour a ...
... Honor, books and DVDs to local schools, SAN ... Medal of Honor Foundation donated 5,000 copies of the,best-selling ... Call of,Duty," to California schools., The book chronicles ... nearly 20 from California, who hold our nation,s,highest award ...
Cached Medicine News:Health News:NxStage Announces $43 Million Private Placement of Equity Securities 2Health News:NxStage Announces $43 Million Private Placement of Equity Securities 3Health News:NxStage Announces $43 Million Private Placement of Equity Securities 4Health News:Linkwell Corporation Runs 24/7 Disinfectant Operations to Support China's Earthquake Relief Efforts 2Health News:Linkwell Corporation Runs 24/7 Disinfectant Operations to Support China's Earthquake Relief Efforts 3Health News:SILS Surgical Technique Now Available at MUMC 2Health News:Let there be light 2Health News:Let there be light 3Health News:TriWest Teaches California Kids About Veteran's Sacrifice, Courage 2
Designed to be removed from under surgical gown without compromising sterile fields. Two straps criss-cross in the back and attach with velcro in the front....
Our 'flex' removes the apron weight from the shoulders while providing back support. Unlike other elastic backs, ours does not wrinkle up, making cleaning easier....
Front protection with choice of adjustable 2" buckle or velcro belt which crosses the back for a comfortable fit. Adjustable straps at shoulders keeps apron snug....
This battery-powered, single-use pulsed stimulator delivers approximately 0.7mA at 80 pulses per second and uses a subdermal needle as the grounding (anode) electrode. A "current flow" confirmation l...
Medicine Products: